Congo, Democratic Republic of the vs Madagascar: The number of people with susceptibility test result for rifampicin
Congo, Democratic Republic of the
22.3
in 2021
Madagascar
15.83
in 2021
Congo, Democratic Republic of the rank
136th
Madagascar rank
137th
The number of people with susceptibility test result for rifampicin over time
- Congo, Democratic Republic of the
- Madagascar
How they compare
Congo, Democratic Republic of the currently reports 22.3 against 15.83 in Madagascar, a difference of 6.47.
That makes Congo, Democratic Republic of the's figure about 1.4 times Madagascar's.
Across all 5 years both countries report, Congo, Democratic Republic of the has been ahead every year.
Congo, Democratic Republic of the ranks 136th and Madagascar ranks 137th of 146 countries.
Congo, Democratic Republic of the has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.66 | 0.0111 | 4.64 | Congo, Democratic Republic of the |
| 2020s | 15.68 | 7.93 | 7.75 | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo, Democratic Republic of the or Madagascar?
- Congo, Democratic Republic of the, at 22.3 against 15.83 in Madagascar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo, Democratic Republic of the and Madagascar?
- 6.47, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Madagascar?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo, Democratic Republic of the and Madagascar rank globally for the number of people with susceptibility test result for rifampicin?
- Congo, Democratic Republic of the ranks 136th and Madagascar ranks 137th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.